Hopantenovaya acid | Calcium hopantenate tablets 0.25 g, 50 pcs.

Release form

tablets

Packing

50 pcs.

Pharmacological action

Calcium hopantenate preparation combines stimulating activity against various manifestations of cerebral insufficiency of exogenous organic origin with anticonvulsant properties. The drug leads to a decrease in motor excitability with a simultaneous streamlining of behavior and an activating effect on performance and mental activity.

Indications

Calcium hopantenate is used in children with mental deficiency (mental retardation) and oligophrenia (cerebrostenic syndrome), with a delay in speech development.

The drug is prescribed as a corrector for side effects of antipsychotics, for antipsychotic extrapyramidal syndrome (hyperkinetic and akinetic), with the preventive purpose simultaneously with antipsychotics - "cover therapy".

Calcium hopantenate is indicated as part of complex therapy or, in some cases, independently for the treatment of children suffering from epilepsy, especially with polymorphic seizures or small epileptic seizures. Adults are prescribed in combination with anticonvulsants for epilepsy.

Calcium hopantenate is used as part of complex therapy and the consequences of neuroinfection (including post-vaccine encephalitis) and traumatic brain injury, cerebral organic failure in patients with schizophrenia.

Calcium hopantenate is indicated for subcortical hyperkinesis of various etiologies. It is used for urinary disorders in children and adults (enuresis and daytime urinary incontinence, pollakiuria, imperative urges, etc.).

Contraindications

Individual intolerance to the drug Calcium hopantenate.

Acute renal failure.

Pregnancy (I trimester).

Special instructions

It is recommended that you consult a specialist before use.

Composition

1 tablet contains: active substance: calcium hopantenate 0.25 g

excipients: basic magnesium carbonate, potato starch, calcium starchic acid, calcium talcum

Dosage and administration

Calcium hopantenate is taken orally, 15-30 minutes after a meal. In the form of mono - and as part of complex therapy. For adults, a single dose is 0.5-1 g, daily - 1.5-3 g. For children, a single dose of 0.25-0.5 g, daily - 0.75-3 g. The course of treatment is 1-4 months, in separate cases - up to 6 months. After 3-6 months, a second course of treatment is possible.

In case of mental failure and oligophrenia in children - 0.5 g 4-6 times a day, daily for 3 months. with a delay in speech development - 0.5 g 3-4 times a day for 2-3 months.

In case of antipsychotic syndrome (side effect of antipsychotics, as a corrector), adults - 0.5-1 g 3 times a day, children - 0.25-0.5 g 3-4 times a day. The course of treatment is 1-3 months.

In case of epilepsy for adults - 0.5-1 g 3-4 times a day for children - 0.25-0.5 g 3-4 times a day. The course of treatment is long (up to 6 months).

With hyperkinesis for adults - 1, 5-3 g per day daily for 1-5 months for children - 0.25-0.5 g 3-6 times a day daily for 1-4 months.

For urination disorders 2-3 times a day, for adults - 0.5-1 g (daily dose - 2-3 g) for children - 0.25-0.5 g (daily dose 25-50 mg / kg) . The course of treatment is 2 weeks - 3 months, depending on the severity of the disease.

Side effects

Calcium hopantenate is low toxic and well tolerated. Allergic reactions are possible (rhinitis, conjunctivitis, skin rashes). In this case, the drug is canceled.

active substance

hopantenic acid

Terms and conditions

prescription

Dosage form

tablet

Pharmstandard-Ufavita, Russia